Evolucare accelerates its external growth with the takeover of ADCIS
Le Pecq, February 15th 2022 Ophthalmology division – OphtAI Evolucare accelerates its external growth. Building on the acquisitions of Cerner France’s PAM-related business in October 2021 and German company HIM in November 2021, on Friday 14 January 2022 Evolucare...
Another successful world challenge for OphtAI
Medium Size Companies, Stars of Innovation – Medicen Round Table
Medicen Paris Region, worldwide competitiveness cluster dedicated to innovative technologies in healthcare, organizes in collaboration with “Mouvement des Entreprises de Taille Intermédiaire” (Movement of the Medium Size Companies), “Club ETI...
A two-fold ambition for Evolucare: international expansion and artificial intelligence
A two-fold ambition for Evolucare: international expansion and Artificial Intelligence. Supported by its new partner, Essling Expansion, Evolucare targets a robust growth both internally and externally. The company is relying on Artificial Intelligence, for instance with its new product OphtAI for the detection of diabetic retinopathy, and international expansion to reach its ambitions.